Clinical Trial Update: Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating repeated doses of praziquantel for schistosomiasis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Praziquantel (Praziquantel)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Schistosomiasis | Phase 3 | Status: COMPLETED